Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 6Gynecologic 4Gastrointestinal 3Other hematologic neoplasm 2Genitourinary 2Endocrine 2NET 1Classical hematology 1CNS 1

Conditions

Multiple Endocrine Neoplasia Type 1 96Pituitary Neoplasms 57Neuroendocrine Tumors 50Thyroid Cancer, Papillary 42Thyroid Neoplasms 16Obesity 15Pheochromocytoma 14Overweight 11Adrenal Gland Neoplasms 10Weight Loss 9Paraganglioma 9Carcinoma, Neuroendocrine 9Pancreatic Neoplasms 8Prostatic Neoplasms 7Motor Activity 7Insulinoma 7Gastrointestinal Neoplasms 7Brain Neoplasms 7Adrenocortical Adenoma 7Acquired Immunodeficiency Syndrome 7Neoplasm Metastasis 6Hyperaldosteronism 6Carcinoma, Medullary 6Stomach Neoplasms 5Osteoporosis 5Neoplasms 5Meningioma 5Liver Neoplasms 5Insulin Resistance 5HIV Infections 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Genetic Predisposition to Disease × Endocrine × Clear all
NCT06377033 2025-07-20

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

University of Pennsylvania

Phase NA Recruiting
1,000 enrolled
CNSEndocrine

Alzheimer Disease, Paraganglioma, Parkinson Disease, Pheochromocytoma, Polyneuropathies, Aortic Aneurysm, Thoracic, Genetic Predisposition to Disease, Frontotemporal Dementia

NCT03622333 2018-08-20

Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)

CHU de Reims

Phase NA Unknown
60 enrolled
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡